financetom
Business
financetom
/
Business
/
Telus to Acquire Telus Digital For Increased Offer of US$4.50 Cash Per Share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Telus to Acquire Telus Digital For Increased Offer of US$4.50 Cash Per Share
Sep 2, 2025 5:21 AM

07:52 AM EDT, 09/02/2025 (MT Newswires) -- Telus ( TU ) (T.TO, TU) was up 1.15% in U.S. pre-market trading on Tuesday after saying it will acquire all of the shares of Telus Digital (TIXT.TO, TIXT) that it does not already own, for US$4.50 per share, up from its previous offer of US$3.40 per share in cash. TIXT was at last look up 14% in premarket at $4.44.

The transaction values Telus Digital equity at US$1.3 billion. Telus ( TU ) currently owns 6% of the subordinate voting shares and 92.5% of the multiple voting shares of Telus Digital.

Telus Digital shareholders can either elect to receive US$4.50 per share held in cash, or 0.273 of a Telus ( TU ) common share, or a combination of US$2.25 in cash and 0.136 of a Telus ( TU ) common share, a statement said.

The transaction has received the unanimous recommendation of a special committee of independent members of the board of directors of Telus Digital and the unanimous approval of Telus Digital's board, and is supported by EQT, Telus Digital's largest minority shareholder.

The transaction has an outside date for completion of Jan. 2, 2026.

Telus ( TU ) is up US$0.19 to US$16.68 in New York trading. It closed up $0.02, to $22.64, on the Toronto Stock Exchange, on Friday.

Telus Digital is up US$0.56 in pre-market trading. It closed up $0.06, to $5.32, on the Toronto Stock Exchange on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan
Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan
Mar 27, 2025
JPMorgan initiated coverage on Ascentage Pharma Group ( AAPG ) , a commercial-stage Chinese biotech company focusing on cancer treatment. In January, Ascentage Pharma’s American depositary shares started trading after the company closed its U.S. initial public offering of 7.325 million ADS at $17.25 per ADS. On Wednesday, JP Morgan said the company’s valuation is largely driven by two late-stage assets...
Update: Sen. Ron Wyden Accuses Pfizer of Tax Dodging After Concluding Investigation
Update: Sen. Ron Wyden Accuses Pfizer of Tax Dodging After Concluding Investigation
Mar 27, 2025
02:52 PM EDT, 03/27/2025 (MT Newswires) -- (Update with Pfizer's ( PFE ) response to a request for comment.) Pfizer ( PFE ) sold $20 billion of drugs to US patients in 2019, but reported zero taxable profits by claiming that 100% of the profits were earned offshore, according to the findings of an investigation conducted by Senate Finance Committee...
US beef sales to China skid after Beijing lets export registrations lapse
US beef sales to China skid after Beijing lets export registrations lapse
Mar 27, 2025
CHICAGO, March 27 (Reuters) - U.S. beef sales to China have taken a dive, U.S. government data showed on Thursday, after Beijing allowed the expiration of registrations that had permitted exports from hundreds of American meat facilities. A tit-for-tat tariff dispute has also raised duties on U.S. meat and other goods shipped to China, making the products less attractive to...
Tesla, Rivian Likely to Fare Better Amid US Tariffs, UBS Says
Tesla, Rivian Likely to Fare Better Amid US Tariffs, UBS Says
Mar 27, 2025
03:08 PM EDT, 03/27/2025 (MT Newswires) -- Tesla (TSLA) and Rivian Automotive ( RIVN ) are likely to fare better after President Donald Trump signed an executive order placing a 25% tariff on automobiles and parts imported to the US, UBS said in a Thursday report. We believe TSLA and RIVN could fare better as 100% of their production is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved